[Allogeneic hematopoetic cell transplantation in patients with solid tumors - Contra].
Bokemeyer
C
C
Abteilung Hämatologie, Onkologie, Immunologie und Rheumatologie, Universitätsklinikum Tübingen.
Kanz
L
L
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D006086:Graft vs Host Disease / Q000276:immunology; D020350:Graft vs Tumor Effect / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012307:Risk Factors; D033581:Stem Cell Transplantation / Q000009:adverse effects; D019172:Transplantation Conditioning / Q000009:adverse effects; D014184:Transplantation, Homologous; D017211:Treatment Failure
D016207:Cytokines